Thank you for visiting my page!
I'm excited to participate in the Defeat Multiple Myeloma Virtual Run/Walk on Sunday, June 28. This event supports Multiple Myeloma cancer research at Fred Hutchinson Cancer Research Center. Approximately 60,000 people in the United States have multiple myeloma and each year, more than 25,000 new patients are diagnosed with this incurable disease. Together, we can support research to find a cure!
As some of you may know, my mom Bambi, was first diagnosed with Multiple Myeloma 11.5 years ago. She underwent chemotherapy for 6 months, that ended with a stem cell transplant in May 2009. Due to the research at Fred Hutch, Seattle Cancer Care and UW Medicine, she went into remission. However, there is no cure yet for this cancer and after nearly 10 years in remission, we heard the news that her cancer came back.
I am committed to helping bring new treatment options to my mom and many other patients faster. By making a tax-deductible contribution to my fundraising goal, you too can help find a cure. You can make a donation online on my fundraising page. Any amount, great or small, helps in the fight against Multiple Myeloma.
Please consider making a tax-deductible donation today in support of my fundraising efforts; 100% of all funds raised will go directly to advancing multiple myeloma cancer research at Fred Hutchinson Cancer Research Center!
What is the Multiple Myeloma?
Multiple Myeloma is a cancer of plasma cells found in bone marrow. Normal plasma cells help the immune system fight disease, but when plasma cells become cancerous they grow out of control and can produce a tumor called a plasmacytoma. If someone has more than one plasmacytoma, they have multiple myeloma.
Why support this event?
Defeat Multiple Myeloma’s mission is to raise awareness of multiple myeloma while supporting research that seeks to discover new treatments, improve the quality of life for myeloma patients, and ultimately find a cure for this devastating form of cancer. Funds from the 2020 Defeat Multiple Myeloma event will continue to support immunotherapy research and clinical trials at Fred Hutch which are using CAR-T cells and have shown very promising early results for patients.